Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
65.40    0.40 (0.62%)
Bid:
65.80
Ask:
66.00
Spread: 0.20 (0.304%)
Market Cap: £577.76m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Total Voting Rights

3 Feb 2025 07:01

RNS Number : 5513V
IP Group PLC
03 February 2025
 

FOR RELEASE ON

03 February 2025

 

IP Group plc - Voting Rights and Capital - Month End Disclosure

Pursuant to Disclosure and Transparency Rule 5.6.1:

As at the date of this announcement, the Company has 967,738,125 Shares in issue and is not holding any Shares in Treasury.

The total number of voting rights in IP Group plc is therefore 967,738,125.

This information may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, the share capital of IP Group plc under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

For further information, please contact:

IP Group plc www.ipgroupplc.com Liz Vaughan-Adams, Communications +44 (0) 20 7444 0062/+44 (0) 7979 853802

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUAVKRVVUAOAR
Date   Source Headline
7th Jan 20262:06 pmRNSPulmocide announces termination of Phase 3 study
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20255:26 pmRNSHolding(s) in Company
4th Dec 20254:13 pmRNSHolding(s) in Company
1st Dec 20255:37 pmRNSTotal Voting Rights
20th Nov 20257:00 amRNSCompletion of share buyback programme
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20251:10 pmRNSArtios completes oversubscribed $115m financing
14th Nov 20255:47 pmRNSTransaction in Own Shares
14th Nov 20258:20 amRNSHolding(s) in Company
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20254:09 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20254:45 pmRNSHolding(s) in Company
10th Nov 20256:02 pmRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20254:51 pmRNSHolding(s) in Company
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20255:14 pmRNSHolding(s) in Company
4th Nov 20256:23 pmRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20255:25 pmRNSTotal Voting Rights
31st Oct 20255:19 pmRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20255:27 pmRNSTransaction in Own Shares
28th Oct 20256:06 pmRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20255:31 pmRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20255:30 pmRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20255:59 pmRNSTransaction in Own Shares
16th Oct 20255:45 pmRNSTransaction in Own Shares
15th Oct 20255:20 pmRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20256:18 pmRNSHolding(s) in Company
13th Oct 20257:00 amRNSPotential income from Metsera obesity drugs
10th Oct 20255:17 pmRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNS-RPortfolio co Monolith to be acquired by CoreWeave
7th Oct 20255:21 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.